Furthermore, the modulation of mTOR by AMPK may be the most crucial anti-tumor effect of AMPK activation by metformin, as the inhibition of mTOR leads to downregulation of protein synthesis and cell proliferation [41]. This evidence concerns the gene PRKAA1 and neoplasm.